XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
CASH FLOW FROM OPERATING ACTIVITIES:    
Net loss $ (736,545) $ (510,285)
Adjustments to reconcile net loss to net cash used for operating activities:    
Depreciation 21,782 23,808
Amortization of intangible assets 76,245 78,005
Amortization of capitalized contract costs 46,545 38,665
Amortization of Note Payable 60,000 0
Interest payable on Note 35,173 0
Operating leases right-of-use assets 6,230 13,686
Share and warrant-based compensation for employees and consultants 52,488 47,790
Stock based directors’ fees 9,002 9,003
Bad debts 15,000 100,000
Change in assets and liabilities:    
Accounts receivable (85,048) 399,749
Due from factor 33,720 91,070
Capitalized contract costs (12,824) (158,005)
Inventory 20,465 5,545
Prepaid expenses and other 24,363 (63,513)
Accounts payable (259,571) (116,012)
Accrued liabilities (236,321) (104,257)
Deferred revenue 95,718 455,868
Operating lease liabilities (1,734) (14,033)
Net cash used in operating activities (835,312) 297,084
CASH FLOWS FROM INVESTING ACTIVITIES:    
Capital expenditures (4,570) (1,869)
Net cash used in investing activities (4,570) (1,869)
CASH FLOW FROM FINANCING ACTIVITIES:    
Offering costs (248,783) (13,470)
Proceeds for exercise of warrants 3,813,057 1,400
Repayment of government loan (35,047) (41,821)
Net cash used in financing activities 3,529,227 (53,891)
Effect of exchange rate changes 6,803 (62,275)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 2,696,148 179,049
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 437,604 511,400
CASH AND CASH EQUIVALENTS, END OF PERIOD 3,133,752 690,449
Cash paid for:    
Interest 737 1,356
Noncash investing and financing activities:    
Issuance of stock for repayment of debt $ 859,000 $ 0